Makara Journal Of Health Reseach Universitas Indonesia (Vol.21 No.2 Agustus 2017) Universitas Indonesia Primary Author mixed material bibliography Jakarta Universitas Indoesia 2017 monographic ISBN P.2356-3656 e.2356-3664 en English

Text

1-34 hlm References 1. Feynman R. There is plenty of room at the bottom: an invitation to enter a new field of physics. Reprinted in: Crandall BC, Lewis J (eds) Nanotech nology: Research And Perspectives., Cambridge, MA: The MIT Press; 1992. p.347-363. 2. Sanna V, Pala N, Sechi M. Targeted therapy using nanotechnology: focus on cancer. Int J Nanomed. 2014;9:467-83. 3. Kunjachan S, Ehling J, Storm G, Kiessling F, Lam mers T. Noninvasive Imaging of Nanomedicines and Nanothera- nostics: Principles, Progress, and Prospects. Chem Rev. 2015;115:10907-37 4. Jagtap P, Sritharan V, Gupta S. Nanotheranostic ap proaches for management of bloodstream bacterial infections. Nanomedicine. 2017;13:329-41. 5. Dai Z (Ed.). 2016. Advances in Nanotheranostics II: Cancer Theranostic Nanomedicine. Singapore: Springer. 6. Schwartz S. Unmet needs in developing nano particles for precision medicine. Nanomedicine. 2017;12:271-4 7. Carmen C, Valentina G, Mariana CC, Keng-Shiang H, Florin I, Yu-Mei L, et al. Nanostructured Approaches for the Targeted Delivery of Antibiotics in Difficult Infections. Curr Org Chem. 2017;21:45-52. 8. Hoop M, Mushtaq F, Hurter C, Chen XZ, Nelson BJ, Pané S. A smart multifunctional drug delivery nano platform for targeting cancer cells. Nanoscale. 2016;8:12723-8. 9. Kateb B, Chiu K, Black KL, Yamamoto V, Khalsa B, Ljubimova JY, et al. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy? Neuroimage. 2011;54 Suppl 1:S106-24. 10. Venuta A, Wolfram J, Shen H, Ferrari M. Post-nano strategies for drug delivery: multistage porous silicon microvectors. J Mater Chem B. 2017;5:207-19. 11. Da Róz AL, Ferreira M, de Lima Leite F, Oliveira ON. 2017. Nanostructures. Cambridge, MA: Elsevier. 12. Moradi-Kalbolandi S, Habibi-Anbouhi M, Golkar M, Behdani M, Rezaei G, Ghazizadeh L, et al. Development of a novel engineered antibody targeting human CD123. Anal Biochem. 2016;511:27-30. 13. Chen Y, Xianyu Y, Jiang X. Surface Modification of Gold Nanoparticles with Small Molecules for Biochemical Analysis. Acc Chem Res. 2017;50:310-9 14. Schaufler V, Czichos-Medda H, Hirschfeld-Warnecken V, Neubauer S, Rechenmacher F, Medda R, et al. Selective binding and lateral clustering of α5β1 and αvβ3 integrins: Anurogo, et al. Makara J. Health Res. August 2017 | Vol. 21 | No. 2 46 Unravelling the spatial requirements for cell spreading and focal adhesion assembly. Cell Adhes Migration. 2016. 15. Liu G, Li K, Luo Q, Wang H, Zhang Z. PEGylated chitosan protected silver nanoparticles as water-borne coating for leather with antibacterial property. J Colloid Interface Sci. 2017;490:642-51. 16. Sandri G, Motta S, Bonferoni MC, Brocca P, Rossi S, Ferrari F, et al. Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and muco adhesion. European J of Pharmaceut Biopharm. 2017;110:13-8. 17. Shitrit Y, Bianco-Peled H. Acrylated chitosan for mucoadhesive drug delivery systems. Int J Pharm. 2017;517:247-55. 18. Wang J, Kong M, Zhou Z, Yan D, Yu X, Cheng X, et al. Mechanism of surface charge triggered intestinal epithelial tight junction opening upon chitosan nanoparticles for insulin oral delivery. Carbohydr Polym. 2017;157:596-602. 19. Shete G, Modi SR, Bansal AK. Effect of Mannitol on Nucleation and Crystal Growth of Amorphous Flavonoids: Implications on the Formation of Nanocrystalline Solid Dispersion. J Pharm Sci. 2015;104:3789-97. 20. Xiao H, Fei-Fei Y, Xiao-Lan W, Guang-Yin Y, Chun-Yu L, Ying Z, et al. Curcumin Acetate Nanocrystals for Sustained Pulmonary Delivery: Preparation, Characterization and In Vivo Evaluation. J Biomed Nanotechnol. 2017;13:99-109. 21. Igarashi E. 2015. Nanomedicines and Nanopro ducts: Applications, Disposition, and Toxicology in the Human Body. CRC Press. Taylor & Francis Group. USA. 22. Wan Y, Moyle PM, Gn PZ, Toth I. Design and evaluation of a stearylated multi component peptide-siRNA nanocomplex for efficient cellular siRNA delivery. Nanomedicine. 2017;12:281-93. 23. Corbet C, Ragelle H, Pourcelle V, Vanvarenberg K, Marchand-Brynaert J, Préat V, et al. Delivery of siRNA targeting tumor metabolism using non-covalent PEGylated chitosan nanoparticles: Identifi cation of an optimal combination of ligand structure, linker and grafting method. J Control Release. 2016;223:53-63. 24. Yan Y, Zhou K, Xiong H, Miller JB, Motea EA, Boothman DA, et al. Aerosol delivery of stabilized polyester-siRNA nanoparticles to silence gene expression in orthotopic lung tumors. Biomaterials. 2017;118:84-93. 25. Edel JB, Albrecht T. 2013. Engineered Nanopores for Bioanalytical Applications. Waltham, MA: Elsevier. 26. Makra I, Brajnovits A, Jágerszki G, Fürjes P, Gyurcsányi R. Potentiometric sensing of nucleic acids using chemically modified nanopores. Nanoscale. 2017;9:739-47. 27. Prando G. Qubits in a row. Nature Nanotechnology. Phys Rev Appl. 2016;6:054013. 28. Credi A (Ed.). 2017. Photoactive Semiconductor Nano- crystal Quantum Dots: Fundamentals and Applications. Springer. Switzerland. ISBN 978-3-319-51192-4. 29. Rodrigues SSM, Riberio DSM, Soares JX, Passos MLC, Saraiva MLMFS, Santos JLM. Application of nanocrystalline CdTe quantum dots in chemical analysis: Implementation of chemo-sensing schemes based on analyte-triggered photoluminescence modulation. Coord Chem Rev. 2017;330:127-43. 30. Devasena T. Diagnostic and Therapeutic Nanomaterials. In: Therapeutic and Diagnostic Nanomaterials. Singapore: Springer; 2017. p. 1-13. 31. Bartneck M, Tacke F. Targeted Modulation of Macrophage Functionality by Nanotheranostics in Inflammatory Liver Disease and Cancer. In: The Immune Response to Implanted Materials and Devices. Switzerland: Springer International Publishing. 32. Evangelopoulos M, Tasciotti E. Bioinspired approaches for cancer nanothera nostics. Nanomedicine. 2017;12:5-7. 33. Jagtap P, Sritharan V, Gupta S. Nanotheranostic approaches for management of bloodstream bacterial infections. Nanomedicine: Nanotechnology. Bio Med. 2017;13:329-41. 34. Arias JL. Drug Targeting by Magnetically Respon sive Colloids. New York: Nova Science Publishers Inc; 2010. 35. Jabr-Milane LS, LE van Vlerken, S Yadav, MM Amiji. Multifunctional nanocarriers to overcome tumor drug resistance. Cancer Treat Rev. 2008;34:592-602. 36. Fang C, M Zhang. Nanoparticle-based theragnostics: Integrating diagnostic and thera peutic potentials in nanomedicine. J Control Release. 2010;146:2-5. 37. Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20-37. 38. Nakamura Y, Mochida A, Choyke PL, Kobayashi H.. Nanodrug Delivery: Is the Enhanced Permeability and Retention Effect Sufficient for Curing Cancer? Bioconjugate Chem. 2016;27:2225-38. 39. Xu X, Ho W, Zhang X, Bertrand N, Farokhzad O. Cancer nanomedicine: from targeted delivery to combination therapy. Trends Mol Med. 2015;21:223-32. 40. Sanna V, Nurra S, Pala N, Marceddu S, Pathania D, Neamati N, et al. Targeted Nanoparticles for the Delivery of Novel Bioactive Molecules to Pancreatic Cancer Cells. J Med Chem. 2016;59:5209-20. 41. Godsey ME, Suryaprakash S, Leong KW. Materials Innovation for Co-delivery of Diverse Therapeutic Cargos. RSC Adv. 2013;3:24794-811. 42. Lao YH, Phua KKL, Leong KW. Aptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation. ACS Nano. 2015;9:2235-54. 43. Karagkiozaki V, Logothetidis S (Eds). Horizons in Clinical Nanomedicine. 2014. USA: CRC Press. Taylor & Francis Group; 2015. p. 2235-54. 44. Charoenphol P, Bermudez H. Aptamer-Targeted DNA Nanostructures for Thera peutic Delivery. Mol Pharmaceut. 2014;11:1721-5. 45. Behrooz AB, Nabavizadeh F, Adiban J, Ardestani MS, Vahabpour R, Aghasadeghi MR, et al. Smart bomb AS1411 aptamer-functionalized/PAMAM dendrimer nanocarriers for targeted drug delivery in the treatment of gastric cancer. Clin Exp Pharmacol Physiol. 2017;44:41-51. 46. Liu J, Wei T, Zhao J, Huang Y, Deng H, Kumar A, et al. Multifunctional aptamer-based nanoparticles for targeted drug delivery to circumvent cancer resistance. Biomaterials. 2016;91:44-56. 47. Chakraborty K, Veetil AT, Jaffrey SR, Krishnan Y. Nucleic Acid–Based Nanodevices in Biological Imaging. Annu Rev Biochem. 2016;85:349-73. 48. Muluhngwi P, Richardson K, Napier J, Rouchka EC, Mott JL, Klinge CM. Regulation of miR-29b-1/a transcription and identification of target mRNAs in CHO-K1 cells. Mol Cell Endocrinol. 2017;444:38-47. 49. Yu M, Wu J, Shi J, Farokhzad OC. Nanotechnology for protein delivery: Overview and perspec tives. J Control Release. 2016;240:24-37. 50. D'Mello SR, Das SK, Das NG. Polymeric nanoparticles for small-molecule drugs. in Y. Pathak and D. Thassu, (Eds.) Drug Delivery Nanoparticles Formulation and Charac- terization. New York: Informa Healthcare; 2009. p. 16-34. Bionanomedicine: A “Panacea” In Medicine? Makara J. Health Res. August 2017 | Vol. 21 | No. 2 47 51. Schönbach C, Nakai K, Tan TW, Ranganathan S. 2010;11. InCoB2010-9th International Conference on Bioin- formatics at Tokyo, Japan, September 26-28, 2010. BMC Bioinformatics. Suppl 7 (SUPPL. 7):S1. 52. Dong Z, Chen Y. Transcrip tomics: advances and approaches. Sci China Life Sci. 2013;56:960-7. 53. Gruber AR, Bernhart SH, Lorenz R. The viennaRNA web services. In: RNA Bioinformatics. 2015:307-26. 54. Hofacker IL, Stadler PF. Memory efficient folding algorithms for circular RNA secondary structures. Bioinformatics. 2006;22:1172-6. 55. Parikesit AA, Steiner L, Stadler PF, Prohaska SJ. Pitfalls of Ascertainment Biases in Genome Annotations— Computing Comparable Protein Domain Distributions in Eukarya. Malaysian J Fundam Appl Sci. 2014;10:65-75. 56. Parikesit AA, Stadler PF, Prohaska SJ. Evolution and Quantitative Compa rison of Genome-Wide Protein Domain Distribu tions. Genes (Basel). 2011;2:912-24. 57. Ben-Ari I, Boushaba K, Matzavinos A, Roitershtein A. Stochastic Analysis of the Motion of DNA Nano- mechanical Bipeds. Bull Math Biol. 2011;73:1932-51. 58. Burnett JC, Rossi JJ. RNA-based therapeutics: current progress and future prospects. Chem Biol. 2012;19:60-71. 59. González-Nilo F, Pérez-Acle T, Guínez-Molinos S, Geraldo DA, Sandoval C, Yévenes A, et al. Nanoinformatics: an emerging area of infor mation technology at the intersection of bioinfor matics, computational chemistry and nanobio technology. Biol Res. 2011;44:43-51. 60. Maojo V, Fritts M, Martin-Sanchez F, De la Iglesia D, Cachau RE, Garcia-Remesal M, et al. Nanoinformatics: developing new computing applications for nanomedicine. Computing. 2012;94:521-39. 61. Akbar Z, Handoko LT. GRID architecture through a public cluster. In: 2008 International Conference on Computer and Communication Engineering. IEEE. 2008:1016-8. 62. Kitchen DB, Decornez H, Furr JR, Bajorath J. Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov. 2004;3:935-49. 63. Karplus M. Molecular dynamics of biological macro- molecules: a brief history and perspective. Biopolymers. 2003;68:350-8. 64. van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov. 2003;2:192-204. 65. Parikesit AA, Ardiansah B, Handayani DM, Tambunan USF, Kerami D. Virtual screening of Indonesian flavonoid as neuraminidase inhibitor of influenza a subtype H5N1. IOP Conf Ser Mater Sci Eng. 2016;107:012053. 66. Kampmann T, Yennamalli R, Campbell P, et al. In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses. Antiviral Res. 2009;84:234-41. 67. Soltero R. Oral Protein and Peptide Drug Delivery. In: Wang B, Siahaan TJ, Soltero R, eds. Drug Delivery: Principles and Application. John Wiley & Sons, Inc; 2005. p.189-200. 68. Julander JG, Bantia S, Taubenheim BR, et al. BCX4430, a novel nucleo side analog, effectively treats yellow fever in a Hamster model. Antimicrob Agents Ch. 2014;58:6607-14. children under two-years, hygiene, sanitation, stu blood glucose, body weight, islet of langerhans, k intracranial aneurysm, hypertension, 64-MDCT angio 610.5/IND/j PERPUSTAKAAN POLTEKKES KEMENKES GORONTALO POLTEKKES KEMENKES GORONTALO 610.5/IND/j 05-JT2018-P5.7 My Library (KOMPUTER) 610.5 IND j JURNAL TERAKREDITASI : Makara Journal Of Health Reseach Universitas Indonesia (Vol.21 No.2 Agustus 2017) Makara_UI_2.jpg.jpg 1484 2018-04-24 08:38:21 2018-04-27 16:23:54 machine generated